|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
|
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
539,854 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,066,843 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
787,387 |
|
|
Total
Value |
$65,005,693 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
1
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
-13.1%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-20 |
473,792 |
2024-05-20 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
|
2024-05-21 |
9,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
852 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 6 of 35
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-05-03 |
4 |
AS |
$16.70 |
$251,807 |
D/D |
(15,000) |
17,695 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-03-02 |
4 |
AS |
$16.44 |
$24,723 |
D/D |
(1,500) |
18,142 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2006-05-01 |
4 |
AB |
$12.55 |
$18,880 |
D/D |
1,500 |
18,500 |
0 |
- |
|
IMUX |
Immunic Inc |
Director |
|
2018-09-24 |
4 |
S |
$0.30 |
$8,002 |
D/D |
(26,619) |
18,500 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-02-28 |
4 |
AS |
$58.00 |
$290,000 |
I/I |
(5,000) |
18,545 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-02-28 |
4 |
OE |
$12.99 |
$64,950 |
I/I |
5,000 |
18,545 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-03 |
4 |
OE |
$12.99 |
$103,920 |
I/I |
8,000 |
18,545 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-05-01 |
4 |
AS |
$36.00 |
$275,069 |
D/D |
(7,453) |
18,667 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-02-22 |
4 |
AS |
$18.40 |
$18,400 |
D/D |
(1,000) |
19,642 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2016-05-05 |
4 |
OE |
$12.99 |
$779,400 |
I/I |
60,000 |
20,000 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-13 |
4 |
GA |
$0.00 |
$0 |
I/I |
7,064 |
20,609 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-13 |
4 |
AS |
$69.11 |
$552,896 |
I/I |
(8,000) |
20,609 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-14 |
4 |
S |
$70.17 |
$1,052,492 |
I/I |
(15,000) |
20,609 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-14 |
4 |
S |
$70.74 |
$1,773,551 |
I/I |
(25,000) |
20,609 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-15 |
4 |
AS |
$68.55 |
$685,477 |
I/I |
(10,000) |
20,609 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-16 |
4 |
AS |
$64.65 |
$129,307 |
I/I |
(2,000) |
20,609 |
0 |
- |
|
NGSX |
Neurogesx Inc |
Director |
|
2009-08-17 |
4 |
S |
$7.21 |
$29,844 |
D/D |
(4,119) |
20,621 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-02-20 |
4 |
AS |
$16.96 |
$220,481 |
D/D |
(13,000) |
20,642 |
0 |
- |
|
IMUX |
Immunic Inc |
Director |
|
2014-04-23 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
20,833 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-05-02 |
4 |
OE |
$6.46 |
$64,600 |
D/D |
10,000 |
21,120 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-04-04 |
4 |
OE |
$6.46 |
$32,300 |
D/D |
5,000 |
21,642 |
0 |
- |
|
NGSX |
Neurogesx Inc |
Director |
|
2011-07-26 |
4 |
A |
$1.65 |
$19,185 |
D/D |
11,627 |
21,748 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2006-04-28 |
4 |
A |
$6.92 |
$23,393 |
D/D |
3,381 |
21,881 |
|
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-12-17 |
4 |
OE |
$6.46 |
$96,900 |
D/D |
15,000 |
22,213 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-01-02 |
4 |
OE |
$6.46 |
$96,900 |
D/D |
15,000 |
22,213 |
0 |
- |
|
852 Records found
|
|
Page 6 of 35 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|